Amarin Corp Plc (AMRN)

[Chas42va]

Evaporate study showed that plaque was significantly reduced within only 9 months ( study going for 18 months)and had the most Reduction for those with the worst situations. this was proven by imaging the arteries. Total plaque was reduced 42% however that was not part of the original target metrics hence the misinformation/confusion

Also the cost benefit study was very favorable – it showed that this was Dominant meaning the cost for the new drugs were less than the benefits received. This is not usually the case as normally there is an additional cost needed to have some medical improvement

Analyst will eventually catch up with their price
targets especially after PDUFA on Or before 12 /28


Long AMRN